---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-011342"
form_type: "8-K"
ticker: null
cik: "0000931059"
company_name: "Rennova Health, Inc."
filed_at: "2024-03-26T23:59:59+00:00"
generated_at: "2026-06-04T08:17:30.522230+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Rennova Health reports expiration of ~403.8B shares of warrants, extends 101.35B Series B warrants to Dec 2025

## Summary
- Warrants to purchase ~403.8 billion shares (Series A, B, C) expired on March 21, 2024, reducing potential dilution.
- Series B warrants for 101.35 billion shares extended from March 21, 2024 to December 31, 2025, subject to exercise conditions.
- Exercise conditions require specified share volumes exercised by dates from April 2024 to August 2025; no cashless exercise counts.
- CEO Seamus Lagan stated the expiration significantly reduces potential dilution and the extension preserves capital access if conditions permit.

## SEC filing metadata
- accession: 0001493152-24-011342
- form_type: 8-K
- cik: 0000931059
- company_name: Rennova Health, Inc.
- filed_at: 2024-03-26T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/931059/000149315224011342/0001493152-24-011342-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/931059/000149315224011342/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-011342
- JSON: https://secwatch.observer/filing/0001493152-24-011342.json
- Plain text: https://secwatch.observer/filing/0001493152-24-011342.txt

## Key facts
- Material Agreements
  Rennova Health, Inc. amended Series B Warrants with certain institutional holders (effective 2024-03-20).
  - Action: amendment
  - Counterparty: certain institutional holders
  - Effective: 2024-03-20
  source text: On March 20, 2024, Rennova Health, Inc. (the “Company”) and certain institutional holders agreed that, with respect to Series B Warrants (originally issued on March 21, 2017), to acquire 101,350,000,000 shares of common stock, the termination date of such warrants would be extended from March 21, 2024 to December 31, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/931059/000149315224011342/0001493152-24-011342-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.